Mechanism for perceiving heart pain

Mechanism for perceiving heart pain in T1-4 dermatomes

Mechanism for perceiving heart pain in T1–T4 dermatomes

Cardiac pain is perceived in the T1–T4 dermatomes because of shared neural pathways between the heart and the upper thoracic spinal cord segments. The heart is innervated primarily by sympathetic afferent fibers that travel alongside sympathetic efferents. These visceral afferents originate from nociceptors in the myocardium, pericardium, and coronary vessels, which respond to ischemia, chemical mediators, and mechanical stretching.

The pain signals travel through the cardiac plexus and ascend via sympathetic cardiac nerves to reach the dorsal root ganglia of spinal segments T1–T4. These same segments also receive somatic sensory input from the skin and musculature of the upper chest, medial arm, and shoulder region. Within the dorsal horn, visceral and somatic afferent fibers converge on the same second-order neurons, a phenomenon known as convergence–projection.

Because the brain is more accustomed to interpreting somatic rather than visceral pain, it “projects” the pain to the somatic region served by the same spinal segments. This misinterpretation results in referred pain felt in the anterior chest wall, inner aspect of the left arm and forearm, axilla, upper back, and sometimes neck and jaw. Additionally, the involvement of the left arm is influenced by asymmetric dominance of left-sided sympathetic afferents in many individuals.

Central sensitization further amplifies the sensation. Persistent myocardial ischemia increases dorsal horn neuron excitability in T1–T4 segments, lowering the threshold for pain perception and widening the referral zone. Higher centers such as the thalamus and insular cortex integrate these inputs, producing the characteristic diffuse, poorly localized nature of anginal pain.

Thus, the overlap of cardiac visceral afferents with somatic afferents in spinal segments T1–T4 forms the anatomical and physiological basis for referred heart pain into these dermatomes.

Comments

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts. The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...

Dr. Usman's Cardiology Notes

Search This Blog